The biological and neurological ability of BDNF to cross the blood-brain barrier and the application of new and novel ...

ALZ, the second Phase 3 study of simufilam in Alzheimer’s disease, expected late first-quarter/early second-quarter ...

Research using ‘network analysis’ techniques, that were first used by physicists, reveals surprising patterns in pain ...

NRx Pharmaceuticals NRXP is expected to report its fourth-quarter 2024 results soon. The Zacks Consensus Estimate for NRXP’s ...

Migraine is a common neurological disorder manifesting as a headache However it has a complex pathophysiology involving the ...